Skip to main content
bioRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search
New Results

AcrIIA22 is a novel anti-CRISPR that impairs SpyCas9 activity by relieving DNA torsion of target plasmids

View ORCID ProfileKevin J. Forsberg, View ORCID ProfileDanica T. Schmidtke, Rachel Werther, View ORCID ProfileDeanna Hausman, Barry L. Stoddard, Brett K. Kaiser, View ORCID ProfileHarmit S. Malik
doi: https://doi.org/10.1101/2020.09.28.317578
Kevin J. Forsberg
aDivision of Basic Sciences Fred Hutchinson Cancer Research Center, Seattle, WA, 98109 USA
bHoward Hughes Medical Institute, Fred Hutchinson Cancer Research Center, Seattle, WA, 98109 USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Kevin J. Forsberg
  • For correspondence: kforsber@fredhutch.org
Danica T. Schmidtke
aDivision of Basic Sciences Fred Hutchinson Cancer Research Center, Seattle, WA, 98109 USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Danica T. Schmidtke
Rachel Werther
aDivision of Basic Sciences Fred Hutchinson Cancer Research Center, Seattle, WA, 98109 USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Deanna Hausman
aDivision of Basic Sciences Fred Hutchinson Cancer Research Center, Seattle, WA, 98109 USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Deanna Hausman
Barry L. Stoddard
aDivision of Basic Sciences Fred Hutchinson Cancer Research Center, Seattle, WA, 98109 USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Brett K. Kaiser
aDivision of Basic Sciences Fred Hutchinson Cancer Research Center, Seattle, WA, 98109 USA
cDepartment of Biology, Seattle University, 901 12th Avenue, Seattle, WA 98122, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Harmit S. Malik
aDivision of Basic Sciences Fred Hutchinson Cancer Research Center, Seattle, WA, 98109 USA
bHoward Hughes Medical Institute, Fred Hutchinson Cancer Research Center, Seattle, WA, 98109 USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Harmit S. Malik
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Preview PDF
Loading

Article usage

Article usage: September 2020 to June 2023

AbstractFullPdf
Sep 20207660183
Oct 202065185242
Nov 2020692349
Dec 2020732745
Jan 2021914653
Feb 2021521717
Mar 2021772930
Apr 2021371021
May 2021862726
Jun 2021563332
Jul 20218715425
Aug 2021381116
Sep 202128816186
Oct 20211644587
Nov 2021471628
Dec 2021541014
Jan 202237121
Feb 20221949
Mar 202227223
Apr 202241515
May 202222425
Jun 202212322
Jul 20222027
Aug 202222112
Sep 202227313
Oct 202217712
Nov 20221809
Dec 20221399
Jan 2023121112
Feb 202311512
Mar 20231437
Apr 202311410
May 2023837
Jun 2023002
Back to top
PreviousNext
Posted September 29, 2020.
Download PDF

Supplementary Material

Email

Thank you for your interest in spreading the word about bioRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
AcrIIA22 is a novel anti-CRISPR that impairs SpyCas9 activity by relieving DNA torsion of target plasmids
(Your Name) has forwarded a page to you from bioRxiv
(Your Name) thought you would like to see this page from the bioRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
AcrIIA22 is a novel anti-CRISPR that impairs SpyCas9 activity by relieving DNA torsion of target plasmids
Kevin J. Forsberg, Danica T. Schmidtke, Rachel Werther, Deanna Hausman, Barry L. Stoddard, Brett K. Kaiser, Harmit S. Malik
bioRxiv 2020.09.28.317578; doi: https://doi.org/10.1101/2020.09.28.317578
Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
AcrIIA22 is a novel anti-CRISPR that impairs SpyCas9 activity by relieving DNA torsion of target plasmids
Kevin J. Forsberg, Danica T. Schmidtke, Rachel Werther, Deanna Hausman, Barry L. Stoddard, Brett K. Kaiser, Harmit S. Malik
bioRxiv 2020.09.28.317578; doi: https://doi.org/10.1101/2020.09.28.317578

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Microbiology
Subject Areas
All Articles
  • Animal Behavior and Cognition (4397)
  • Biochemistry (9623)
  • Bioengineering (7118)
  • Bioinformatics (24928)
  • Biophysics (12658)
  • Cancer Biology (9985)
  • Cell Biology (14395)
  • Clinical Trials (138)
  • Developmental Biology (7986)
  • Ecology (12141)
  • Epidemiology (2067)
  • Evolutionary Biology (16021)
  • Genetics (10947)
  • Genomics (14774)
  • Immunology (9896)
  • Microbiology (23730)
  • Molecular Biology (9501)
  • Neuroscience (51037)
  • Paleontology (370)
  • Pathology (1544)
  • Pharmacology and Toxicology (2690)
  • Physiology (4035)
  • Plant Biology (8687)
  • Scientific Communication and Education (1512)
  • Synthetic Biology (2404)
  • Systems Biology (6453)
  • Zoology (1349)